腹水市場：依腹水類型、腹水嚴重程度、治療類型、臨床分級、給藥途徑、通路、最終用戶、地區分類

預計到 2025 年，腹水市場價值將達到 14.8 億美元，到 2032 年將達到 23 億美元，2025 年至 2032 年的複合年成長率為 6.5%。

全球腹水市場是更廣泛的治療領域中的重要細分市場，該領域旨在解決腹腔內異常積液這種嚴重疾病。

腹水主要表現為肝硬化的併發症，約佔所有病例的80%，但也可能由惡性腫瘤、心臟衰竭、腎臟疾病和其他潛在疾病引起。目前市面上有多種治療方法，包括利尿劑、腹水穿刺術、經頸靜脈肝內門體分流術（TIPS）、腹膜靜脈分流術，以及在嚴重病例中進行肝臟移植。

肝臟疾病，尤其是非酒精性脂肪肝（NAFLD）和酒精性肝病的日益流行，以及全球乙型和丙型肝炎感染病例的不斷增加，都顯著推高了需要進行腹水治療的患者數量。此外，全球人口老化以及各種可導致惡性腹水的癌症發生率上升，也進一步擴大了市場規模。

全球醫療系統都認知到腹水對病患和醫療資源帶來的沉重負擔，因此迫切需要更有效的診斷工具、治療性介入和管理策略。微創手術的技術進步、新型藥物的研發以及診斷影像技術的改進，持續推動市場的發展。

市場動態

全球腹水市場受到幾個關鍵因素的驅動，這些因素支撐著市場的持續成長，主要是由於全球肝硬化患病率的上升，而肝硬化患病率的上升是由於酒精消費量的增加、病毒性肝炎感染以及與肥胖和糖尿病相關的非酒精性脂肪肝疾病的迅速蔓延所致。

已開發國家和開發中國家醫療保健支出的成長擴大了先進診斷程序和治療方案的覆蓋範圍，同時，腹腔穿刺術、超音波引導手術以及新型利尿劑配方等技術創新正在改善患者預後和治療效果。然而，該市場也面臨可能阻礙其成長潛力的重大限制因素。

經經皮肝內門靜脈分流術（TIPS）和肝移植等先進手術的高昂費用構成了就醫障礙，尤其是在醫療基礎設施薄弱的新興經濟體。此外，某些手術的侵入性以及對感染疾病和電解質紊亂等併發症的擔憂，往往會影響患者的依從性和醫生的推薦。

此外，不同醫療體系之間缺乏標準化的治療通訊協定，以及某些地區對早期診斷和治療的認知不足，都構成了重大挑戰。儘管有這些限制，市場格局仍蘊藏著巨大的機會。人們對個人化醫療的日益關注，以及針對誘發腹水的原發疾病的標靶治療的研發，為製藥公司帶來了廣闊的前景。亞太和拉丁美洲等新興市場，由於醫療基礎設施的不斷改善和醫療意識的提高，蘊藏著巨大的成長潛力。

本次調查的主要特點

• 本報告對全球腹水市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
• 我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
• 該研究還提供了有關市場促進因素、阻礙因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
• 該研究根據以下參數對全球腹水市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
• 這份全球腹水市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過用於分析全球腹水市場的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場範圍

• 報告概述
  • 市場定義和範圍
• 執行摘要

第3章 市場動態、監理及趨勢分析

• 市場動態
• 促進要素
• 抑制因素
• 機會
• 影響分析
• 重大進展
• 法規環境
• 產品上市及核准
• PEST分析
• 波特分析
• 併購趨勢
• 產業趨勢

4. 2020-2032年全球腹水市場（以腹水類型分類）

• 滲漏性腹水
• 滲出性腹水
• 惡性腹水
• 乳糜腹水
• 出血性腹水
• 感染性腹水

5. 2020-2032年全球腹水市場（以腹水嚴重程度分類）

• 單純性腹水
• 復發性/難治性腹水

6. 2020-2032年全球腹水市場依治療類型分類

• 藥物治療（利尿劑、白蛋白療法、血管加壓素受體拮抗劑、抗生素、標靶癌症治療）
• 穿刺（治療性穿刺、大塊穿刺、影像引導下穿刺）
• 外科介入手術（經腔肝內門體分流術、腹膜靜脈分流術、留置導管及引流系統）
• 其他

7. 2020-2032年全球腹水市場（依臨床等級分類）

• 一年級
• 二年級
• 三年級

8. 2020-2032年全球腹水治療藥物市場（依給藥途徑分類）

• 口服
• 腸外

9. 2020-2032年全球腹水市場依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

第10章 全球腹水市場（依最終用戶分類），2020-2032年

• 醫院
• 專科診所
• 門診手術中心
• 居家醫療環境

第11章 2020-2032年全球腹水市場（按地區分類）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第12章 競爭格局

• Baxter International
• Fresenius Kabi
• CSL Behring
• Grifols SA
• Pfizer Inc
• Novartis AG
• Otsuka Pharmaceutical
• Bayer AG
• AstraZeneca
• Cook Medical
• Boston Scientific
• Medtronic
• Becton Dickinson
• Cardinal Health
• Teleflex

第13章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第14章 參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Ascites Market is estimated to be valued at USD 1.48 Bn in 2025 and is expected to reach USD 2.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

The global ascites market represents a critical segment within the broader therapeutic landscape, addressing a serious medical condition characterized by abnormal fluid accumulation in the peritoneal cavity.

Ascites primarily manifests as a complication of liver cirrhosis, accounting for approximately 80% of cases, though it can also result from malignancies, heart failure, kidney disease, and other underlying pathological conditions. This market encompasses various treatment modalities including diuretics, paracentesis procedures, transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunts, and liver transplantation in severe cases.

The increasing prevalence of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, coupled with rising cases of hepatitis B and C infections globally, has significantly contributed to the growing patient population requiring ascites management. Additionally, the aging global population and increasing incidence of various cancers that can lead to malignant ascites have further expanded the market scope.

Healthcare systems worldwide are recognizing the substantial burden that ascites places on both patients and healthcare resources, driving demand for more effective diagnostic tools, therapeutic interventions, and management strategies. The market continues to evolve with technological advancements in minimally invasive procedures, development of novel pharmaceutical agents, and improved diagnostic imaging techniques.

Market Dynamics

The global ascites market is propelled by several key drivers that collectively contribute to its sustained growth trajectory. The primary driver stems from the escalating prevalence of liver cirrhosis worldwide, fueled by increasing alcohol consumption, viral hepatitis infections, and the rapidly growing epidemic of non-alcoholic fatty liver disease associated with obesity and diabetes.

Rising healthcare expenditure in developed and developing nations has enhanced access to advanced diagnostic procedures and treatment options, while technological innovations in paracentesis techniques, ultrasound-guided procedures, and development of novel diuretic formulations have improved patient outcomes and treatment efficacy. However, the market faces significant restraints that could impede its growth potential.

High treatment costs associated with advanced procedures like TIPS and liver transplantation create accessibility barriers, particularly in emerging economies with limited healthcare infrastructure. The invasive nature of certain procedures and associated complications, including infection risks and electrolyte imbalances, often deter patient compliance and physician recommendations.

Additionally, the lack of standardized treatment protocols across different healthcare systems and insufficient awareness about early diagnosis and management in certain regions pose considerable challenges. Despite these constraints, substantial opportunities exist within the market landscape. The increasing focus on personalized medicine and development of targeted therapies for underlying conditions causing ascites present lucrative prospects for pharmaceutical companies. Emerging markets in Asia-Pacific and Latin America offer significant expansion potential due to improving healthcare infrastructure and rising healthcare awareness.

Key Features of the Study

• This report provides in-depth analysis of the global ascites market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ascites market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Baxter International, Fresenius Kabi, CSL Behring, Grifols SA, Pfizer Inc, Novartis AG, Otsuka Pharmaceutical, Bayer AG, AstraZeneca, Cook Medical, Boston Scientific, Medtronic, Becton Dickinson, Cardinal Health, and Teleflex
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global ascites market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ascites market

Market Segmentation

• Ascites Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Transudative Ascites
  • Exudative Ascites
  • Malignant Ascites
  • Chylous Ascites
  • Hemorrhagic Ascites
  • Infectious Ascites
• Ascites Severity Insights (Revenue, USD Bn, 2020 - 2032)
  • Uncomplicated Ascites
  • Recurrent/Refractory Ascites
• Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
  • Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
  • Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
  • Others
• Clinical Grade Insights (Revenue, USD Bn, 2020 - 2032)
  • Grade 1
  • Grade 2
  • Grade 3
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Parenteral
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Baxter International
  • Fresenius Kabi
  • CSL Behring
  • Grifols SA
  • Pfizer Inc
  • Novartis AG
  • Otsuka Pharmaceutical
  • Bayer AG
  • AstraZeneca
  • Cook Medical
  • Boston Scientific
  • Medtronic
  • Becton Dickinson
  • Cardinal Health
  • Teleflex

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Ascites Market, By Ascites Type
  • Global Ascites Market, By Ascites Severity
  • Global Ascites Market, By Treatment Type
  • Global Ascites Market, By Clinical Grade
  • Global Ascites Market, By Route of Administration
  • Global Ascites Market, By Distribution Channel
  • Global Ascites Market, By End User
  • Global Ascites Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Ascites Market, By Ascites Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Transudative Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Exudative Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Malignant Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chylous Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hemorrhagic Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Ascites Market, By Ascites Severity, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Uncomplicated Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Recurrent/Refractory Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Ascites Market, By Treatment Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Ascites Market, By Clinical Grade, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Grade 1
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Grade 2
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Grade 3
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Ascites Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Ascites Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Ascites Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Ascites Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive Landscape

• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius Kabi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grifols SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Otsuka Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cook Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton Dickinson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About us